KEGG   DRUG: Enoxaparin sodium
Entry
D03674                      Drug                                   
Name
Enoxaparin sodium (JAN/USP/INN);
Lovenox (TN)
Product
LOVENOX (Cardinal Health 107), LOVENOX (Sanofi-Aventis U.S. LLC), LOVENOX (Sanofi-Aventis U.S. LLC)
  Generic
ENOXAPARIN SODIUM (Amphastar Pharmaceuticals), ENOXAPARIN SODIUM (BE Pharmaceuticals), ENOXAPARIN SODIUM (BluePoint Laboratories), ENOXAPARIN SODIUM (Cardinal Health 107), ENOXAPARIN SODIUM (Cardinal Health 107), ENOXAPARIN SODIUM (Cardinal Health 107), ENOXAPARIN SODIUM (Fresenius Kabi USA), ENOXAPARIN SODIUM (Fresenius Kabi USA), ENOXAPARIN SODIUM (Fresenius Kabi USA), ENOXAPARIN SODIUM (Fresenius Kabi USA), ENOXAPARIN SODIUM (Gland Pharma Limited), ENOXAPARIN SODIUM (Hepalink USA), ENOXAPARIN SODIUM (Italfarmaco SpA), ENOXAPARIN SODIUM (Meitheal Pharmaceuticals), ENOXAPARIN SODIUM (Meitheal Pharmaceuticals), ENOXAPARIN SODIUM (Meitheal Pharmaceuticals), ENOXAPARIN SODIUM (Meitheal Pharmaceuticals), ENOXAPARIN SODIUM (Meitheal Pharmaceuticals), ENOXAPARIN SODIUM (NorthStar Rx LLC), ENOXAPARIN SODIUM (NorthStar RxLLC), ENOXAPARIN SODIUM (Sagent Pharmaceuticals), ENOXAPARIN SODIUM (Sandoz), ENOXAPARIN SODIUM (Winthrop U.S), ENOXAPARIN SODIUM (Zydus Pharmaceuticals USA), ENOXAPARIN SODIUM INJECTION,USP (Sandoz)
Class
Blood modifier agent
 DG01950  Antithrombotic agent
  DG01709  Heparin anticoagulant
Remark
Therapeutic category: 3339
ATC code: B01AB05
Chemical structure group: DG00150
Product (DG00150): D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US>
Efficacy
Anticoagulant, Antithrombin III activator
Comment
Sodium salt of a low-molecular weight Heparin [CPD:C00374] obtained by alkaline depolymerization of the benzyl ester of Heparin from porcine mucosa.
Low molecular weight heparin (LMWH)
Target
SERPINC1 (AT3) [HSA:462] [KO:K03911]
  Pathway
hsa04610  Complement and coagulation cascades
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B01 ANTITHROMBOTIC AGENTS
   B01A ANTITHROMBOTIC AGENTS
    B01AB Heparin group
     B01AB05 Enoxaparin
      D03674  Enoxaparin sodium (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
 Blood Products and Modifiers
  Anticoagulants
   Low Molecular Weight Heparins
    Enoxaparin
     D03674  Enoxaparin sodium (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  33  Blood and body fluid agents
   333  Anticoagulants
    3339  Others
     D03674  Enoxaparin sodium (JAN/USP/INN)
Drug groups [BR:br08330]
 Blood modifier agent
  DG01950  Antithrombotic agent
   DG01709  Heparin anticoagulant
    DG00150  Heparin
     D03674  Enoxaparin sodium
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Complement and coagulation
    SERPINC1 (AT3)
     D03674  Enoxaparin sodium (JAN/USP/INN) <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D03674
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D03674
Drug groups [BR:br08330]
 Blood modifier agent
  DG01950  Antithrombotic agent
   DG01709  Heparin anticoagulant
    DG00150  Heparin
Other DBs
CAS: 679809-58-6
PubChem: 17397770
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system